Analysis of MTHFR 1298A>C in addition to MTHFR 677C>T polymorphism as a risk factor for neural tube defects in the Turkish population

Turkish Journal of Pediatrics

Volumn 47, Issue 4, 2005, Pages 327-333

  Boduroǧlu, Koray ^a   Alanay, Yasemin ^a   Alikaşifoǧlu, Mehmet ^a   Aktaş, Dilek ^a   Tunçbilek, Ergül ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Methylenetetrahydrofolate reductase; MTHFR; MTHFR 1298A>C polymorphism; MTHFR 677C>T polymorphism; Neural tube defects; Polymorphism

Indexed keywords

FOLIC ACID; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ALLELE; ARTICLE; BLOOD SAMPLING; CHILD; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEURAL TUBE DEFECT; PARENT; POPULATION DISTRIBUTION; PREVALENCE; PROGENY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TURKEY (REPUBLIC);

EID: 31344476035     PISSN: 00414301     EISSN: 00414301     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGe review. Am J Epidemiol 2000; 151: 862-877.
2. Center for Disease Control and Prevention (CDCP) recommendations for use of folic acid to reduce number of spina bifida cases and other neural tube defects. JAMA 1993; 269: 1233-1238.
3. Tuncbilek E, Boduroglu K, Alikasifoglu M. Neural tube defects in Turkey: prevalence, distribution and risk factors. Turk J Pediatr 1999; 41: 299-305.
4. Czeizel AE, Dudas I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327: 1832-1835.
5. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 341: 131-137.
6. Bailey LB, Gregory J. Polymorphisms of methylenetet rahydrofolate reductase and other enzymes: metabolic significance, risks, and impact on folate requirement. J Nutr 1999; 129: 919-922.
7. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
8. van der Put NM, Steegers-Theunissen RP, Frosst P, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995; 346: 1070-1071.
9. Whitehead AS, Gallagher P, Mills JL, et al. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. Q J Med 1995; 88: 763-766.
10. Ou CY, Stevenson RE, Brown VY, et al. 5,10 methyle netetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 1996; 63: 610-614.
11. Christensen B, Arbour L, Tran P, et al. Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet 1999; 84: 151-157.
12. de Francis R, Buoninconti A, Mandato C, et al. The C677T mutation of the 5,10-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy. J Med Genet 1998; 35: 1009-1013.
13. Shields DC, Kirke PN, Mills JL, et al. The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: an evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet 1999; 64: 1045-1055.
14. Boduroglu K, Alikasifoglu M, Anar B, et al. Association of the 677C→T mutation on the methylenetetrahydro folate reductase gene in Turkish patients with neural tube defects. J Child Neurol 1999; 14: 159-161.
15. Mornet E, Muller F, Lenvoisé-Furet A, et al. Screening of the C677T mutation on the methylenetetrahydrof olate reductase gene in French patients with neural tube defects. Hum Genet 1997; 100: 512-514.
16. Morrison K, Papapetrou C, Hol FA, et al. Susceptibility to spina bifida; an association study of five candidate genes. Ann Hum Genet 1998; 62: 379-396.
17. Richter B, Stegmann K, Röper B, et al. Interaction of folate and homocysteine pathway genotypes evaluated in susceptibility to neural tube defects (NTD) in a German population. J Hum Genet 2001; 46: 105-109.
18. Chango A, Boisson F, Barbe F, et al. The effect of 677C→T and 1298A→C mutations on plasma homocysteine and 5,10- methylenetetrahydrofolate reductase activity in healthy subjects. Br J Nutr 2000; 83: 593-596.
19. van der Put NM, Gabreels F, Stevens BE, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural tube defects? Am J Hum Genet 1998; 62: 1044-1051.
20. Parle-McDermott A, Mills JL, Kirke PN, et al. Analysis of the MTHFR 1298A→C and 677C→T polymorphisms as risk factors for neural tube defects. J Hum Genet 2003; 48: 190-193.
21. Perez ABA, D'Almeida V, Vergani N, et al. Methyle netetrahydrofolate reductase (MTHFR): incidence of mutations C677T and A1298C in Brazilian population and its correlation with plasma homocysteine levels in spina bifida. Am J Med Genet 2003; 119A: 20-25.
22. De Marco P, Calevo MG, Moroni A, et al. Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J Hum Genet 2002; 47: 319-324.
23. James SJ, Pogribna M, Pogribny IP, et al. Abnormal folate metabolism and mutation in the methylenete trahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr 1999; 70: 495-501.
24. Stegmann K, Ziegler A, Ngo ET, et al. Linkage disequilibrium of MTHFR genotypes 677C/T-1298A/C in the German population and association studies in probands with neural tube defects (NTD). Am J Med Genet 1999; 87: 23-29.
25. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism. in methylenete trahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Molec Genet Metabol 1998; 63: 169-172.
26. Dekou V, Whincup P, Papacosta O, et al. The effect of the C677T and A1298C polymorphisms in the methylenetetrahydrofolate reductase gene on homocysteine levels in elderly men and women from the British regional heart study. Atherosclerosis 2001; 154: 659-666.
27. Song C, Xing D, Tan W, et al. Methylenetetrahydrofola te reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 2001; 61: 3272-3275.
28. Akar N, Akar E, Deda G, et al. Spina bifida and common mutations at the homocysteine metabolism pathway. Clin Genet 2000; 57: 230-231.